Line 107: | Line 107: | ||
<section> | <section> | ||
− | To achieve all these novel functions, we designed a genetic circuit that is distributed over two de novo synthesized DNA molecules. All functions were tested and optimized to make the resulting circuit as safe and well characterized as possible. | + | To achieve all these novel functions, we designed a genetic circuit that is distributed over two de novo synthesized DNA molecules. All functions were tested and optimized to |
+ | make the resulting circuit as safe and well characterized as possible. | ||
+ | <br> | ||
+ | <br> | ||
+ | <a href="https://2017.igem.org/Team:ETH_Zurich/#" class="more">Circuit</a> | ||
</section> | </section> | ||
Revision as of 09:48, 19 October 2017
We need more specific therapies because current approaches result in many side-effects. That's why we invented CATE, the first all-in-one
living cancer therapeutic with an integrated two-step safety mechanism. That's why we created CATE: Cancer-Targeting E. coli.
A living cure to a living disease.
Background
It features two safety checkpoint mechanisms to ensure only tumor cells are damaged.
Description
Treatment
Circuit